The stock price of Cybin Inc (AMEX: CYBN) has dropped by 0.00 compared to previous close of 0.35. Despite this, the company has seen a fall of -2.89% in its stock price over the last five trading days. Business Wire reported 2024-04-10 that TORONTO–(BUSINESS WIRE)–Cybin Inc. (NYSE American:CYBN) (Cboe CA:CYBN) (“Cybin” or the “Company”), a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new and innovative next-generation psychedelic treatment options, is pleased to announce that Doug Drysdale, Cybin’s Chief Executive Officer, will present at the 2024 Bloom Burton & Co. Healthcare Investor Conference, taking place April 16-17, 2024 in Toronto, Ontario. Mr. Drysdale’s prese.
Is It Worth Investing in Cybin Inc (AMEX: CYBN) Right Now?
Analysts have mixed views on the stock, with 0 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for CYBN is 643.65M, and currently, short sellers hold a 3.65% ratio of that float. The average trading volume of CYBN on April 30, 2024 was 5.40M shares.
CYBN’s Market Performance
The stock of Cybin Inc (CYBN) has seen a -2.89% decrease in the past week, with a -15.36% drop in the past month, and a -6.89% fall in the past quarter. The volatility ratio for the week is 3.67%, and the volatility levels for the past 30 days are at 6.12% for CYBN. The simple moving average for the last 20 days is -10.05% for CYBN’s stock, with a simple moving average of -15.64% for the last 200 days.
CYBN Trading at -9.92% from the 50-Day Moving Average
After a stumble in the market that brought CYBN to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -52.57% of loss for the given period.
Volatility was left at 6.12%, however, over the last 30 days, the volatility rate increased by 3.67%, as shares sank -17.47% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +2.94% upper at present.
During the last 5 trading sessions, CYBN fell by -2.89%, which changed the moving average for the period of 200-days by -24.73% in comparison to the 20-day moving average, which settled at $0.3854. In addition, Cybin Inc saw -14.63% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for CYBN
The total capital return value is set at -0.58. Equity return is now at value -78.03, with -72.76 for asset returns.
Based on Cybin Inc (CYBN), the company’s capital structure generated 0.0 points at debt to capital in total, while cash flow to debt ratio is standing at -162.52. The debt to equity ratio resting at 0.0. The interest coverage ratio of the stock is -564.93.
Currently, EBITDA for the company is -54.69 million with net debt to EBITDA at 0.55. The liquidity ratio also appears to be rather interesting for investors as it stands at 5.76.
Conclusion
To put it simply, Cybin Inc (CYBN) has had a bad performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
